Quick Comparison

Licorice Root ExtractTranexamic Acid
Typical ConcentrationConcentrations vary; glabridin at 0.1-0.4% is the most active brightening component. Full extract at 1-4%. Apply morning and/or night. Safe for all skin types. Often combined with niacinamide and arbutin for enhanced brightening.Topical: 2-5% in serum or cream, applied twice daily. Oral (off-label for melasma): 250 mg twice daily — requires medical supervision. Can be combined with other brightening agents. Results visible at 8-12 weeks. Especially effective for melasma.
ApplicationTopical (serum, cream, toner). Very stable in formulation. Compatible with most active ingredients.Topical (serum, cream) or oral (tablets, off-label). Topical preferred for safety. Oral is more effective but carries systemic risks.
Research Papers10 papers10 papers
Categories

Mechanism of Action

Licorice Root Extract

Glabridin competitively inhibits tyrosinase by binding copper active site (CuA, CuB), blocking tyrosine to L-DOPA hydroxylation and DOPA to dopaquinone oxidation. Also inhibits tyrosinase-related protein 1 (TRP-1). Liquiritin disperses existing melanin via melanosome transfer inhibition and autophagy pathway upregulation in keratinocytes. Glycyrrhizin inhibits COX-2 and 5-lipoxygenase, reducing prostaglandin and leukotriene production. Multi-mechanism brightening: tyrosinase inhibition, melanin dispersal, anti-inflammation. Unlike hydroquinone, no melanocyte cytotoxicity — suitable for long-term use and all skin tones. Glabridin has free radical scavenging antioxidant activity. Glycyrrhizin's 11-beta-HSD inhibition has minimal systemic effect with topical use.

Tranexamic Acid

Tranexamic acid (TXA) is a lysine analogue that competitively inhibits plasminogen activation—binding lysine-binding sites and preventing conversion to plasmin by tPA and uPA. Plasmin normally activates multiple pathways: converts latent TGF-beta to active form, stimulates keratinocyte release of arachidonic acid and prostaglandins (PGE2, PGF2-alpha), and increases SCF and bFGF—all stimulating melanocyte proliferation and melanogenesis. By blocking plasmin, TXA interrupts this paracrine cascade, reducing melanin through a mechanism independent of tyrosinase. TXA also inhibits VEGF and reduces angiogenesis—addressing melasma's vascular component. May reduce UV-induced plasmin in keratinocytes. This unique mechanism makes TXA synergistic with tyrosinase inhibitors for stubborn melasma.

Risks & Safety

Licorice Root Extract

Common

Very well-tolerated.

Serious

None documented topically. Oral licorice (glycyrrhizin) can elevate blood pressure, but topical use does not have this effect.

Rare

Allergic contact dermatitis.

Tranexamic Acid

Rare

Topical form has minimal systemic absorption and low risk.

Full Profiles